Core Laboratories (NYSE:CLB) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Core Laboratories (NYSE:CLB) from a sell rating to a hold rating in a research note released on Saturday morning.

Separately, Weiss Ratings lowered shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce”.

Core Laboratories Stock Up 2.9%

Shares of NYSE CLB opened at $10.65 on Friday. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36. The company has a current ratio of 2.12, a quick ratio of 1.50 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $490.87 million, a price-to-earnings ratio of 19.01, a PEG ratio of 2.57 and a beta of 1.00. The business has a 50-day moving average of $12.01 and a 200-day moving average of $15.23.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.02. The company had revenue of $124.61 million for the quarter, compared to analysts’ expectations of $126.26 million. Core Laboratories had a net margin of 5.10% and a return on equity of 10.03%. Core Laboratories’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.19 earnings per share. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Sell-side analysts expect that Core Laboratories will post 0.53 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Monday, August 10th will be issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, August 10th. Core Laboratories’s dividend payout ratio is presently 7.14%.

Hedge Funds Weigh In On Core Laboratories

Several institutional investors have recently modified their holdings of the company. Disciplined Growth Investors Inc. MN lifted its position in Core Laboratories by 9.7% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock worth $73,787,000 after buying an additional 528,976 shares during the last quarter. Vanguard Group Inc. boosted its stake in Core Laboratories by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 3,079,882 shares of the oil and gas company’s stock worth $49,371,000 after buying an additional 32,492 shares in the last quarter. State Street Corp grew its position in Core Laboratories by 3.3% during the fourth quarter. State Street Corp now owns 2,041,740 shares of the oil and gas company’s stock valued at $32,729,000 after acquiring an additional 64,831 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Core Laboratories by 10.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,352,329 shares of the oil and gas company’s stock valued at $22,705,000 after acquiring an additional 122,718 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Core Laboratories by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 1,114,935 shares of the oil and gas company’s stock worth $17,876,000 after acquiring an additional 8,497 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

Key Stories Impacting Core Laboratories

Here are the key news stories impacting Core Laboratories this week:

• Positive Sentiment: Core Laboratories reported second-quarter adjusted EPS of $0.11, above the $0.08 analyst consensus. Production Enhancement performance helped offset weakness in the Reservoir Description business. Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y
• Positive Sentiment: Operating income excluding special items increased 42% sequentially, while adjusted EPS rose 85% from the prior quarter. The company also repurchased 214,712 shares for $2.7 million, supporting per-share value. Core Lab Reports Second Quarter 2026 Results
• Positive Sentiment: Management and analysts described the earnings call as indicating a gradual recovery, with sequential revenue and profitability improvement providing a potential foundation for a broader turnaround. Core Laboratories Earnings Call Signals Gradual Recovery
• Neutral Sentiment: Core Laboratories declared a $0.01 quarterly dividend, payable August 31 to shareholders of record August 10. The dividend provides income support, but its annualized yield is only about 0.4%.
• Negative Sentiment: Second-quarter revenue fell 4.3% year over year to $124.6 million, below the roughly $126.3 million consensus, while adjusted EPS declined from $0.19 a year earlier. Free cash flow was modest at $3.1 million. Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
• Negative Sentiment: Third-quarter EPS guidance of $0.12–$0.20 is broad and includes a level below the $0.17 consensus estimate. The company expects revenue of $128.5–$135.5 million, signaling only a gradual recovery. Analysts also remain cautious after a sharp six-month selloff and ongoing geopolitical pressure.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.